Kymera Therapeutics, Inc. IPO

Kymera Therapeutics placed 8 684 800 shares in an IPO priced $20 per share. This is 2 dollars higher than the upper limit of the originally stated range ($16-18). Besides, Kymera gave the underwriters a 30 day-option to purchase up to 1 302 720 common shares at the IPO price. The debut trade will take place on the Nasdaq Global Market on August 21, 2020 under the ticker symbol “KYMR”.